MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 01-10-2025
Accolade EPS Ratio 2011-2025 | ACCD
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.72 | -9.13 | -12.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.72 | -12.2 | -7.67 |
Quarterly EPS Ratio Accolade
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.5 | -0.3 | -0.35 | - | -0.28 | -0.43 | -0.52 | - | -0.56 | -0.66 | -4.92 | - | 0.34 | -1.41 | -1.81 | - | -0.32 | -1.5 | -0.47 | -1.86 | -3.17 | -2.82 | -3.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.34 | -4.92 | -1.36 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Health information services industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Covetrus
CVET
|
-0.39 | - | - | $ 2.94 B |  USA |
 |
Cerner Corporation
CERN
|
1.86 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
-3.15 | - | 4.4 % | $ 133 M | USA |
 |
iCAD
ICAD
|
-0.21 | - | - | $ 102 M | USA |
 |
Change Healthcare
CHNG
|
-0.18 | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
-0.2 | $ 4.09 | -0.97 % | $ 383 M | USA |
 |
Health Catalyst
HCAT
|
-1.15 | $ 2.51 | 3.51 % | $ 151 M | USA |
 |
HealthStream
HSTM
|
0.66 | $ 23.24 | -1.59 % | $ 706 M | USA |
 |
MTBC
MTBC
|
-0.28 | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
-0.51 | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
0.65 | $ 92.73 | -0.8 % | $ 7.93 B | USA |
 |
Progyny
PGNY
|
0.12 | $ 25.6 | -0.78 % | $ 2.2 B | USA |
 |
American Well Corporation
AMWL
|
-13.9 | $ 4.59 | 0.55 % | $ 68.8 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.03 | - | -10.39 % | $ 886 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-1.03 | $ 12.24 | -1.92 % | $ 210 M | USA |
 |
Schrödinger
SDGR
|
-2.57 | $ 17.87 | -2.4 % | $ 1.3 B | USA |
 |
GoodRx Holdings
GDRX
|
0.04 | $ 2.7 | -1.82 % | $ 1.04 B | USA |
 |
Omnicell
OMCL
|
0.27 | $ 46.28 | -0.26 % | $ 2.13 B | USA |
 |
1Life Healthcare
ONEM
|
-1.64 | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
-2.51 | $ 16.93 | -0.38 % | $ 924 M | USA |
 |
Premier
PINC
|
0.22 | $ 28.26 | - | $ 2.33 B | USA |
 |
10x Genomics
TXG
|
-2.18 | $ 16.13 | -2.21 % | $ 1.89 B | USA |
 |
R1 RCM
RCM
|
-1.86 | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-8.8 | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
0.14 | - | - | $ 1.6 B | USA |
 |
Zhongchao
ZCMD
|
-0.12 | $ 0.42 | -17.6 % | $ 2.19 M |  China |
 |
Signify Health
SGFY
|
-3.27 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-2.53 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-5.87 | $ 6.93 | -2.74 % | $ 1.18 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-6.07 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
3.27 | $ 224.73 | 0.04 % | $ 36.1 B | USA |
 |
SCWorx Corp.
WORX
|
-0.78 | $ 0.2 | -3.56 % | $ 292 K | USA |